Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Adenocarcinoma Of Esophagus × tremelimumab × Clear all

Phase

Phase 2 2 Phase 1/2 2 Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urethral Neoplasms 1 Ureteral Neoplasms 1 Pancreatic Neoplasms 1 Melanoma 1 Hydronephrosis 1 Carcinoma, Renal Cell 1 Anatomic Stage II Breast Cancer AJCC v8 1 Adenocarcinoma Of Esophagus 1

Interventions

tremelimumab 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06824363 2026-01-30

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

University of California, Irvine

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡